The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Milliken & Co sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Milliken & Co, United States Revenue

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Milliken & Company (Milliken) primarily carries out the development and manufacturing of a wide range of products. The company’s main activities include the production of textile, chemical, and floor covering performance solutions. Milliken‘s products are designed to serve various purposes such as protecting first responders, aiding in wound healing, safeguarding food, and enhancing environmental health. Its products find applications across diverse industries and the company also offers consulting and training solutions to its clients. The company operates through a network of manufacturing facilities and sales and service operations. Milliken has a global presence across Americas, Europe, and Asia, offering local market expertise and manufacturing efficiencies. Milliken is headquartered in Spartanburg, South Carolina, the US. Key subsidiaries of Milliken & Co include Milliken Healthcare Products, Optimal Karpet (Orka), Milliken Textiles, Encapsys and Zebra-chem.

The key metrics of Milliken & Co related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:

As Milliken & Co is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Milliken & Co.

For a detailed understanding of the performance of Milliken & Co, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.